Study on the regulatory effect of hepatocellular derived liver precursor-like cells on macrophages
PENG Yuan1, ZHOU Xun2, JING Hong-Shu1, ZHU Xue-Jing2, SHI Yao-Ping1, WANG Tao1, CUI Dan1, SI Dong-Hua1, YAN He-Xin1,2, ZHAI Bo1
1. Department of Interventional Oncology, Renji Hospital, Jiaotong University School of Medicine, Shanghai 200127, China; 2. Celliver Biotechnology Inc., Shanghai 200127, China
PENG Yuan, ZHOU Xun, JING Hong-Shu, ZHU Xue-Jing, SHI Yao-Ping, WANG Tao, CUI Dan, SI Dong-Hua, YAN He-Xin, ZHAI Bo. Study on the regulatory effect of hepatocellular derived liver precursor-like cells on macrophages[J]. Chinese Hepatolgy, 2021, 26(6): 684-687.
[1] Fu GB, Huang WJ, Zeng M, et al. Expansion and differentiation of human hepatocyte-derived liver progenitor-like cells and their use for the study of hepatotropic pathogens. Cell Res, 2019, 29: 8-22.
[2] Li WJ, Zhu XJ, Yuan TJ, et al. An extracorporeal bioartificial liver embedded with 3D-layered human liver progenitor-like cells relieves acute liver failure in pigs. Sci Transl Med, 2020, 12: undefined.
[3] Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol, 2011, 11: 723-737.
[4] Fang P, Li XY, Dai J, et al. Immune cell subset differentiation and tissue inflammation. J Hematol Oncol, 2018, 11: 97.
[5] Tacke F, Zimmermann HW. Macrophage heterogeneity in liver injury and fibrosis. J Hepatol, 2014, 60: 1090-1096.
[6] Tacke F. Targeting hepatic macrophages to treat liver diseases. J Hepatol, 2017, 66: 1300-1312.
[7] Kazankov K, Jørgensen SMD, Thomsen KL, et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol, 2019, 16: 145-159.
[8] Krenkel O, Mossanen JC, Tacke F. Immune mechanisms in acetaminophen-induced acute liver failure. Hepatobiliary Surg Nutr, 2014, 3: 331-343.